Models &
Molecules
Inside the digital transformation of drug discovery

Talip Uçar: Inside Boltz's open-source bet on the future of AI-driven drug discovery
About the podcast
At the intersection of computation and biology, Models & Molecules explores how data, algorithms, and science come together to design the medicines of tomorrow.
Each episode features candid conversations with the people shaping this transformation, from pharma R&D leaders to computational biologists and AI innovators, about the ideas, challenges, and technologies redefining how drugs are discovered.
Produced by ENPICOM, Models & Molecules offers a rare look behind the buzzwords of AI-driven discovery, uncovering the practical realities, lessons learned, and moments of insight that emerge when biology meets computation.
Previous episodes

From novel binder design to the realities of AI in complex therapeutics
April 14, 2026
From lab-in-the-loop to zero-shot: The role of cloud and AI agents
March 3, 2026
Navigating the convergence of tech and pharma
January 28, 2026
From rabies to COVID: Antibody discovery in the age of AI
December 16, 2025
Taking risks and driving innovation in biopharma
November 4, 2025Never miss an episode
Subscribe for monthly insights from the biologics R&D leaders shaping drug discovery.
Thank you for signing up!